ADMS's logo.
Ticker Symbol: ADMS

Adamas Pharmaceuticals Inc

$8.15 - 13-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001328143

Company Profile

Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1900 Powell St Ste 1000
CEO: Neil McFarlane
Tags:
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: $0.06 ( 0.73%)
Days Range: $8.22 - $8.22
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.73%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 45786965

Valuation

Market Cap: 37.6B
PE Ratio: -5.07
EPS (TTM): -1.62

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A